Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.R. Bryan Bell, Andrew D. Weinberg, Carlo Bifulco et al.|Journal of Clinical Oncology|2018Cited by 27
Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resectionRom S. Leidner, Marka R. Crittenden, R. Bryan Bell et al.|Cancer Research|2019Cited by 4
Abstract B01: Surgical outcomes following neoadjuvant hypofractionated radiation in combination with nivolumab: High rate of pathologic complete response in patients with p16+ head and neck squamous cell carcinomaR. Bryan Bell, Marka R. Crittenden, Rom S. Leidner et al.|Clinical Cancer Research|2020Cited by 1
Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resectionRom S. Leidner, Marka R. Crittenden, R. Bryan Bell et al.|Clinical Trials|2019Cited by 1